---
description: 刘小泽写于2020.10.30
---

# 2.2.5 研究 \| 原汁原味读--单细胞肿瘤免疫图谱

> 探索一种新的文献阅读方法，可以更快去理解到作者的主体思路 下面我会从这几块介绍：SOURCE（文章来源）、WHY（作者为什么做这个项目）、HOW（作者怎么做的项目）、GET WHAT（作者得到了什么主要结论）
>
> 其中不会有特别复杂的词语和语法，而且我会尽可能把文章逻辑层级写清楚

## SOURCE

Title: A Single-Cell Tumor Immune Atlas for Precision Oncology

Date: 2020-10-26

Team: Barcelona Institute of Science and Technology \(BIST\), Barcelona, Spain

Paper Link: [https://www.biorxiv.org/content/10.1101/2020.10.26.354829v1](https://www.biorxiv.org/content/10.1101/2020.10.26.354829v1)

Data Link \(Restricted Access\): [https://zenodo.org/record/4036020\#.X5uoHlMzaHF](https://zenodo.org/record/4036020#.X5uoHlMzaHF)

Code Link: [https://github.com/Single-Cell-Genomics-Group-CNAG-CRG/Tumor-Immune-Cell-Atlas](https://github.com/Single-Cell-Genomics-Group-CNAG-CRG/Tumor-Immune-Cell-Atlas)

## WHY？

* Immune microenvironments vary profoundly between patients and biomarkers for prognosis and treatment response lack precision
* To pinpoint predictive cellular states of tumor immune cells and their spatial localization

## HOW？

* Analyzing **&gt;500,000** cells from **217** patients and **13** cancer types
* Data projection: Seurat's anchor-transferring method
* Using **SPOTlight** to combine single-cell and spatial transcriptomics data and identifying striking spatial immune cell patterns in tumor sections
* **ShinyApp** \(in progress\) to project external data and to apply the immune classifier

## GET WHAT?

### **GET 1: Generating a tumor immune cell atlas**

* Collected scRNA-seq datasets from **13 different cancer types**, 217 patients and 526,261 cells

  ![image-20201030104337329](https://jieandze1314-1255603621.cos.ap-guangzhou.myqcloud.com/blog/2020-10-30-024337.png)

* Immune cells clustered by cell identity rather than patient origin: integrated **317,111** immune cells using **canonical correlation analysis** =&gt;  **25**  clusters

  ![image-20201030104248148](https://jieandze1314-1255603621.cos.ap-guangzhou.myqcloud.com/blog/2020-10-30-024248.png)

### **GET2: Tumor subtype classifier**

* **For Current:** to establish a pan-cancer immune classification system
  * used **immune cell type and state frequencies** of the reference atlas as input for similarity assessment across the 13 cancer types

    ![image-20201030105045062](https://jieandze1314-1255603621.cos.ap-guangzhou.myqcloud.com/blog/2020-10-30-025045.png)

  * A **hierarchical k-means clustering** using immune cell proportions as features defined six clusters with largely different compositions \(almost all cancer types were presented in each cluster\)

    ![image-20201030105413983](https://jieandze1314-1255603621.cos.ap-guangzhou.myqcloud.com/blog/2020-10-30-025414.png)
* **For future**: to facilitate the classification of immune profiles
  * trained an **RF\(random forest\) classifier** with the 25 immune cell population achieving a highly accurate classification 
  * using the classifier, the pan-cancer immune classification system could be extended to **additional cancer types**

### **GET 3: A resource for immune cell annotation**

> To demonstrate the potential value of the atlas

* The applicability of the atlas as reference **across different cancer types**

  * **First:** Project cells onto atlas using a reference-based projection \(**Fig. A**\)
  * **Next**: Typical clustering matching \(**Fig. B**\)

   ![image-20201030111226885](https://jieandze1314-1255603621.cos.ap-guangzhou.myqcloud.com/blog/2020-10-30-031227.png)

  * **Third**: Check correlation \(**Fig. C**\) 

  ![image-20201030112148461](https://jieandze1314-1255603621.cos.ap-guangzhou.myqcloud.com/blog/2020-10-30-032149.png)

* The applicability of the atlas as reference **across species**
  * two liver metastases derived from **mouse CRC organoids**
  * main subtypes and specific subpopulations could also be assigned **using the human reference**

    ![image-20201030112314187](https://jieandze1314-1255603621.cos.ap-guangzhou.myqcloud.com/blog/2020-10-30-032314.png)

### **GET 4: Spatial localization of immune cells in tumor sections**

> **Spatial** distribution of immune cells is important for **ICI \(immune checkpoint inhibitors\) response**

* Single-cell reference atlas immune profiles + Spatial transcriptome data
* **SPOTlight** : non-negative matrix factorization \(NMF\) based spatial deconvolution framework
* Analysis of oropharyngeal squamous cell carcinoma \(**SCC**\)

  * **cluster 1/2** \(cancer cells\) is surrounded by **cluster 0** \(stroma\) and **cluster 3** \(immune cells\) 

  ![image-20201030113032968](https://jieandze1314-1255603621.cos.ap-guangzhou.myqcloud.com/blog/2020-10-30-033033.png)

  * **cluster1/2** presented a similar immune infiltration pattern, with an enrichment of proliferative **T-cells** and **SPP1 macrophages**
  * **cluster 3** presented a distinct immune infiltration pattern characterized by an enriched presence of \(proliferative\) **B-cells**
  * **cluster 0** harbored regulatory T-cells and terminally exhausted CD8 T-cells and was specifically enriched in **M2 macrophages** and **naive T-cells.**

    ![image-20201030132328526](https://jieandze1314-1255603621.cos.ap-guangzhou.myqcloud.com/blog/2020-10-30-052329.png)

* Analysis of ductal breast carcinoma \(**BC**\)
  * also get a cancer-specific regional distribution: 

    ![image-20201030134113951](https://jieandze1314-1255603621.cos.ap-guangzhou.myqcloud.com/blog/2020-10-30-054114.png)

  * subclonal  was directly associated with local enrichment of distinct immune cell states

    ![image-20201030133721287](https://jieandze1314-1255603621.cos.ap-guangzhou.myqcloud.com/blog/2020-10-30-053721.png)
* **Foresee** the regional distribution of immune cell types to become an important feature for the prediction of immuno-therapy outcome.

